These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

747 related articles for article (PubMed ID: 17499343)

  • 1. Venous thromboembolism in carriers of the Factor V Leiden mutation and in patients without known thrombophilic risk factor; prediction of recurrence and APC-PCI complex concentration and/or soluble thrombomodulin antigen and activity.
    Strandberg K; Svensson PJ; Ohlin AK
    Thromb Res; 2007; 121(2):145-51. PubMed ID: 17499343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of factor VIII/von Willebrand complex on the activated protein C-resistance phenotype and on the risk for venous thromboembolism in heterozygous carriers of the factor V Leiden mutation.
    De Mitrio V; Marino R; Scaraggi FA; Di Bari L; Giannoccaro F; Petronelli M; Ranieri P; Tannoia N; Schiraldi O
    Blood Coagul Fibrinolysis; 1999 Oct; 10(7):409-16. PubMed ID: 10695766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombin generation in first-degree relatives of patients with venous thromboembolism who have factor V Leiden. A pilot study.
    Couturaud F; Duchemin J; Leroyer C; Delahousse B; Abgrall JF; Mottier D;
    Thromb Haemost; 2008 Jan; 99(1):223-8. PubMed ID: 18217158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probability of recurrence of thrombosis in patients with and without factor V Leiden.
    Rintelen C; Pabinger I; Knöbl P; Lechner K; Mannhalter C
    Thromb Haemost; 1996 Feb; 75(2):229-32. PubMed ID: 8815565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The risk of recurrent venous thromboembolism in patients with and without factor V Leiden.
    Eichinger S; Pabinger I; Stümpflen A; Hirschl M; Bialonczyk C; Schneider B; Mannhalter C; Minar E; Lechner K; Kyrle PA
    Thromb Haemost; 1997 Apr; 77(4):624-8. PubMed ID: 9134632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low plasma activated protein C-protein C inhibitor complex concentration is associated with vascular access failure in hemodialysis patients.
    Bakoush O; Ohlin AK; Strandberg K; Kurkus J
    Nephron Clin Pract; 2008; 110(3):c151-7. PubMed ID: 18953177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factor V Leiden mutation carriership and venous thromboembolism in polycythemia vera and essential thrombocythemia.
    Ruggeri M; Gisslinger H; Tosetto A; Rintelen C; Mannhalter C; Pabinger I; Heis N; Castaman G; Missiaglia E; Lechner K; Rodeghiero F
    Am J Hematol; 2002 Sep; 71(1):1-6. PubMed ID: 12221665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are patients with thrombophilia and previous venous thromboembolism at higher risk to arterial thrombosis?
    Linnemann B; Schindewolf M; Zgouras D; Erbe M; Jarosch-Preusche M; Lindhoff-Last E
    Thromb Res; 2008; 121(6):743-50. PubMed ID: 17804043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activated protein C levels in Behçet's disease and risk of venous thrombosis.
    Navarro S; Ricart JM; Medina P; Vayá A; Villa P; Todolí J; Estellés A; Micó ML; Aznar J; España F
    Br J Haematol; 2004 Aug; 126(4):550-6. PubMed ID: 15287949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombin generation and activated protein C resistance in the absence of factor V Leiden correlates with the risk of recurrent venous thromboembolism in women aged 18-65 years.
    Sonnevi K; Tchaikovski SN; Holmström M; Rosing J; Bremme K; Lärfars G
    Thromb Haemost; 2011 Nov; 106(5):901-7. PubMed ID: 21947267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-segregation of thrombophilic disorders in factor V Leiden carriers; the contributions of factor VIII, factor XI, thrombin activatable fibrinolysis inhibitor and lipoprotein(a) to the absolute risk of venous thromboembolism.
    Libourel EJ; Bank I; Meinardi JR; Baljé -Volkers CP; Hamulyak K; Middeldorp S; Koopman MM; van Pampus EC; Prins MH; Büller HR; van der Meer J
    Haematologica; 2002 Oct; 87(10):1068-73. PubMed ID: 12368162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive value of D-dimer test for recurrent venous thromboembolism after anticoagulation withdrawal in subjects with a previous idiopathic event and in carriers of congenital thrombophilia.
    Palareti G; Legnani C; Cosmi B; Valdré L; Lunghi B; Bernardi F; Coccheri S
    Circulation; 2003 Jul; 108(3):313-8. PubMed ID: 12847064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hereditary thrombophilic risk factors and venous thromboembolism in Istanbul, Turkey: the role in different clinical manifestations of venous thromboembolism.
    Okumus G; Kiyan E; Arseven O; Tabak L; Diz-Kucukkaya R; Unlucerci Y; Abaci N; Unaltuna NE; Issever H
    Clin Appl Thromb Hemost; 2008 Apr; 14(2):168-73. PubMed ID: 17895505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombin generation and D-dimer concentrations in a patient cohort investigated for venous thromboembolism. Relations to venous thrombosis, factor V Leiden and prothrombin G20210A. The LIST study.
    Chaireti R; Jennersjö C; Lindahl TL
    Thromb Res; 2009 Jun; 124(2):178-84. PubMed ID: 19232683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factor V HR2 haplotype: a risk factor for venous thromboembolism in individuals with absence of Factor V Leiden.
    Otrock ZK; Taher AT; Shamseddeen WA; Zaatari G; Bazarbachi A; Mahfouz RA
    Ann Hematol; 2008 Dec; 87(12):1013-6. PubMed ID: 18654780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The Bavarian Thromboembolic Risk Cohort Study (BATER). Study protocol, state of the investigation and first results].
    Schramm W; Heinemann LA; Spannagl M; Dick A; Assmann A
    Dtsch Med Wochenschr; 2000 Jan; 125(1-2):2-6. PubMed ID: 10650817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prevalence of thrombophilia and venous thromboembolism in total knee arthroplasty.
    Chotanaphuti T; Ongnamthip P; Silpipat S; Foojareonyos T; Roschan S; Reumthantong A
    J Med Assoc Thai; 2007 Jul; 90(7):1342-7. PubMed ID: 17710975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factor V Leiden mutation and the risk of venous thromboembolism in pregnant women.
    Tormene D; Simioni P; Prandoni P; Luni S; Zerbinati P; Sartor D; Franz F; Girolami A
    Haematologica; 2001 Dec; 86(12):1305-9. PubMed ID: 11726323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coexistence of factor V Leiden and Factor II A20210 mutations and recurrent venous thromboembolism.
    Margaglione M; D'Andrea G; Colaizzo D; Cappucci G; del Popolo A; Brancaccio V; Ciampa A; Grandone E; Di Minno G
    Thromb Haemost; 1999 Dec; 82(6):1583-7. PubMed ID: 10613638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early identification of acute myocardial infarction by activated protein C--protein C inhibitor complex.
    Bhiladvala P; Strandberg K; Stenflo J; Holm J
    Thromb Res; 2006; 118(2):213-9. PubMed ID: 16098566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.